LONDON (Reuters) - European makers of emergency allergy treatments are stepping up production of alternative life-saving adrenaline shots to try to fill intermittent shortages of Mylan's market-leading EpiPen injection.
Original Article: In Europe, Mylan's rivals try to plug EpiPen shortages